Market Tracker

09/23 5:16pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

3.45
Delayed Data
As of Sep 23
 +0.03 / +0.88%
Today’s Change
2.44
Today|||52-Week Range
10.60
-60.44%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close3.42
Today’s open3.38
Day’s range3.34 - 3.47
Volume358,027
Average volume (3 months)702,147
Market cap$182.2M
Dividend yield--
Data as of 3:59pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-44.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
INNLInnocoll Holdings PL...-0.04-0.68%
PRQRProQR Therapeutics N...+0.44+6.15%
OCULOcular Therapeutix I...-0.04-0.56%
MDWDMediwound Ltd+0.09+1.12%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts